IBS symptoms improve with sugar and starch reduction

Bodil Ohlsson is a professor at Lund University and consultant at Skåne University Hospital. Her choice to investigate the role of sugars and starches in IBS is linked to a geneticist’s discovery: a genetic variation that hinders the breakdown of sugars and starches in the gut is overrepresented among IBS patients.

Lilly takes more actions against unapproved versions of Mounjaro

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Here in

June 20, 2024

PathAI and Google Cloud Partner to Advance AI-Powered Pathology for Biopharma and Labs

What You Should Know: – PathAI, a leading force in AI-powered pathology, has joined forces with Google Cloud at the Bio-IT World Conference & Expo

April 17, 2024

Reprieve for WuXi as Biosecure vote likely pushed to 2025 – Pharmaceutical Technology

The Biosecure Act was left out of a key US defence bill that passed in the House this week, in a major win for Chinese

December 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.